Omeros reported $-30849000 in Net Income for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Acelrx Pharmaceuticals ACRX:US $ 70.66M 79.34M
Aerie Pharmaceuticals AERI:US $ -19.37M 16.52M
Alnylam Pharmaceuticals ALNY:US $ -277.4M 37.06M
Biomarin Pharmaceutical BMRN:US $ 27.66M 93.13M
Cytokinetics CYTK:US $ -19.82M 69.62M
Dynavax Technologies DVAX:US $ 128.76M 95.9M
Gilead Sciences GILD:US $ 1144M 1125M
Insmed INSM:US $ -95645000 1.02M
Intercept Pharmaceuticals ICPT:US $ -7.53M 9.76M
Knight Therapeutics Inc GUD:CN C$ 2.52M 21.33M
Macrogenics MGNX:US $ -41.3M 25.14M
Mirati Therapeutics MRTX:US $ -176.44M 11.94M
Omeros OMER:US $ -30849000 2.16M
Pacira Pharmaceuticals PCRX:US $ 19.88M 13.05M
Pfizer PFE:US $ 9905M 2042M
Regulus Therapeutics RGLS:US $ -7.26M 0.54M
Rockwell Medical RMTI:US $ -4.97M 2.19M
Sangamo Biosciences SGMO:US $ -43.17M 0.8M
Sarepta Therapeutics SRPT:US $ -231.48M 126.46M
United Therapeutics UTHR:US $ 116M 123.9M
Vertex Pharmaceuticals VRTX:US $ 810.5M 48.4M
Vital Therapies VTL:US $ -21.9M 1.09M
Xoma XOMA:US $ -4670000 2.39M